• About
    • ICNMD 2022 Photos
    • ICNMD2026 Call For Proposals
    • Call For Volunteers
    • About ICNMD
    • ICNMD 2022 Committees
    • Related Events & Partners
    • Past Congresses
    • Contact
  • Venue
    • About Brussels
    • About Meeting Venue
  • Registration & Accommodation
    • Health & Safety Measures
    • Social Events
    • Registration
    • Remote Viewing Pass
    • Accommodation
  • Program
    • Full Program
    • CME Accreditation
    • Teaching & Hands-on Courses
    • Speakers and Working Groups
    • Speaker Resources
    • Patient’s Day
    • Call for Abstracts
  • Sponsorship & Exhibits
    • Sponsorship & Exhibit Opportunities
    • Confirmed Sponsors 2022
    • Confirmed Exhibitors 2022
    • Industry-Supported Symposia 2022
    • View ICNMD 2021 Recordings
    • ICNMD 2021 Program at a Glance
    • ICNMD 2021 Abstracts
    • ICNMD 2021 Industry-Supported Symposia
    • ICNMD 2021 Product Theatre
    • ICNMD 2022 Photos
    • ICNMD2026 Call For Proposals
    • Call For Volunteers
    • About ICNMD
    • About Brussels
    • About Meeting Venue
    • ICNMD 2022 Committees
    • Related Events & Partners
    • Past Congresses
    • Contact
    • Full Program
    • CME Accreditation
    • Teaching & Hands-on Courses
    • Speakers and Working Groups
    • Speaker Resources
    • Patient’s Day
    • Call for Abstracts
    • Health & Safety Measures
    • Social Events
    • Registration
    • Remote Viewing Pass
    • Accommodation
    • Sponsorship & Exhibits Opportunities
    • Confirmed Sponsors 2022
    • Confirmed Exhibitors 2022
    • Industry-Supported Symposia 2022
    • About Brussels
    • About Meeting Venue
  • About
    • ICNMD 2022 Photos
    • ICNMD2026 Call For Proposals
    • Call For Volunteers
    • About ICNMD
    • ICNMD 2022 Committees
    • Related Events & Partners
    • Past Congresses
    • Contact
  • Venue
    • About Brussels
    • About Meeting Venue
  • Registration & Accommodation
    • Health & Safety Measures
    • Social Events
    • Registration
    • Remote Viewing Pass
    • Accommodation
  • Program
    • Full Program
    • CME Accreditation
    • Teaching & Hands-on Courses
    • Speakers and Working Groups
    • Speaker Resources
    • Patient's Day
    • Call for Abstracts
  • Sponsorship & Exhibits
    • Sponsorship & Exhibit Opportunities
    • Confirmed Sponsors 2022
    • Confirmed Exhibitors 2022
    • Industry-Supported Symposia 2022
Get Tickets!

Program at a Glance

[widget id="nav_menu-11"][widget id="custom_html-3"]

Last updated: 6 April 2021

View CME Accreditation Information

May 8, 2021
May 21, 2021
May 22, 2021
May 28, 2021
May 29, 2021

12:00
12:10
12:20
12:30
12:40
12:50
13:00
13:10
13:20
13:30
13:40
13:50
14:00
14:10
14:20
14:30
14:40
14:50
15:00
15:10
15:20
15:30
15:40
15:50
16:00
16:10
16:20
16:30
16:40
16:50
17:00
17:10
17:20
17:30
17:40
17:50
18:00
Teaching Courses
Teaching Courses
TC 1.0 Systemic Features in Neuromuscular Disorders (12:00 CEST / 06:00 EDT / 03:00 PDT)
12:00 - 13:40
- Involvement of the heart <br> - Brain Involvement in Myotonic Dystrophy Type 2 <br> - When to investigate for neoplasia? <br> - Rhabdomyolysis

Start Time: 12:00 CEST / 06:00 EDT / 03:00 PDT
Duration: 1hour 40minutes

Presenations
- Involvement of the heart
- Brain Involvement in Myotonic Dystrophy Type 2
- When to investigate for neoplasia?
- Rhabdomyolysis

TC 2.0 Differential diagnosis of acute and chronic neuropathies (12:00 CEST / 06:00 EDT / 03:00 PDT)
12:00 - 13:40
- Approach to the Patient with Peripheral Neuropathy <br> - Differential Diagnosis and treatment of Acute Neuropathy <br> - Approach to the Patient with Hereditary Peripheral Neuro <br> - Diagnosis and Treatment of Diabetic Neuropathy

Time: 12:00 CEST / 06:00 EDT / 03:00 PDT
Duration: 1hour 40minutes

Presenations
- Approach to the Patient with Peripheral Neuropathy
- Differential Diagnosis and treatment of Acute Neuropathy
- Approach to the Patient with Hereditary Peripheral Neuro
- Diagnosis and Treatment of Diabetic Neuropathy

TC 3.0 Differential Diagnosis of Common Clinical Presentations (14:00 CEST / 08:00 EDT / 05:00 PDT)
14:00 - 15:30
- Limb girde syndrome <br> - External ophthalmoplegia <br> - Bulbar Balsy

Time: 14:00 CEST / 08:00 EDT / 05:00 PDT
Duration: 1hour 30minutes

Presenations
- Limb girde syndrome
- External ophthalmoplegia
- Bulbar Balsy

TC 4.0 Practical Approaches to Sensory Neuropathies (14:00 CEST / 08:00 EDT / 05:00 PDT)
14:00 - 15:30
- Bulbar Weakness Inherited sensory and autonomic neuropathies: new clues on diagnosis and treatment <br>- Sensory Variants of Immune-Mediated Neuropathies; Clinical Challenges and Treatments <br>- Chemotherapy related sensory and painful neuropathies: strategies for prevention and treatment <br>- Small fibre neuropathy: from diagnosis to personalized treatments

Time: 14:00 CEST / 08:00 EDT / 05:00 PDT
Duration: 1hour 40minutes

Presenations
- Bulbar Weakness Inherited sensory and autonomic neuropathies: new clues on diagnosis and treatment
- Sensory Variants of Immune-Mediated Neuropathies; Clinical Challenges and Treatments
- Chemotherapy related sensory and painful neuropathies: strategies for prevention and treatment
- Small fibre neuropathy: from diagnosis to personalized treatments

TC 5.0 Ultrasound in muscle and nerve diseases (16:00 CEST / 10:00 EDT / 07:00 PDT)
16:00 - 17:00

Time: 16:00 CEST / 10:00 EDT / 07:00 PDT
Duration: 1hour 40minutes

Teaching Courses
  • TC 1.0 Systemic Features in Neuromuscular Disorders (12:00 CEST / 06:00 EDT / 03:00 PDT)
    - Involvement of the heart
    - Brain Involvement in Myotonic Dystrophy Type 2
    - When to investigate for neoplasia?
    - Rhabdomyolysis
    12:00 - 13:40
  • TC 2.0 Differential diagnosis of acute and chronic neuropathies (12:00 CEST / 06:00 EDT / 03:00 PDT)
    - Approach to the Patient with Peripheral Neuropathy
    - Differential Diagnosis and treatment of Acute Neuropathy
    - Approach to the Patient with Hereditary Peripheral Neuro
    - Diagnosis and Treatment of Diabetic Neuropathy
    12:00 - 13:40
  • TC 3.0 Differential Diagnosis of Common Clinical Presentations (14:00 CEST / 08:00 EDT / 05:00 PDT)
    - Limb girde syndrome
    - External ophthalmoplegia
    - Bulbar Balsy
    14:00 - 15:30
  • TC 4.0 Practical Approaches to Sensory Neuropathies (14:00 CEST / 08:00 EDT / 05:00 PDT)
    - Bulbar Weakness Inherited sensory and autonomic neuropathies: new clues on diagnosis and treatment
    - Sensory Variants of Immune-Mediated Neuropathies; Clinical Challenges and Treatments
    - Chemotherapy related sensory and painful neuropathies: strategies for prevention and treatment
    - Small fibre neuropathy: from diagnosis to personalized treatments
    14:00 - 15:30
  • TC 5.0 Ultrasound in muscle and nerve diseases (16:00 CEST / 10:00 EDT / 07:00 PDT)
    16:00 - 17:00

 

12:00
12:10
12:20
12:30
12:40
12:50
13:00
13:10
13:20
13:30
13:40
13:50
14:00
14:10
14:20
14:30
14:40
14:50
15:00
15:10
15:20
15:30
15:40
15:50
16:00
16:10
16:20
16:30
16:40
16:50
17:00
17:10
17:20
17:30
17:40
17:50
18:00
Muscle Disorders
Muscle Disorders
Industry Supported Symposia (12:00 CEST / 06:00 EDT / 03:00 PDT)
12:00 - 12:45

Time: 12:00 CEST / 06:00 EDT / 03:00 PDT
Duration: 45 minutes

Opening Session (13:00 CEST / 07:00 EDT / 04:00 PDT)
13:00 - 14:00

Start Time: 13:00 CEST / 07:00 EDT / 04:00 PDT
Duration: 1hour

SS 1.0 News on FSHD (14:00 CEST / 08:00 EDT / 05:00 PDT)
14:00 - 15:00
- FSHD: Setting the Stage <br> - FSHD: Genetics, Epigenetics and Genetic Diagnosi <br> - FSHD: Biomarkers, Outcome Measures and Therapies

Start Time: 14:00 CEST / 08:00 EDT / 05:00 PDT
Duration: 1hour

Presenations
- FSHD: Setting the Stage
- FSHD: Genetics, Epigenetics and Genetic Diagnosi
- FSHD: Biomarkers, Outcome Measures and Therapies

WS 1.0 Muscle Biopsy (14:00 CEST / 08:00 EDT / 05:00 PDT)
14:00 - 15:00
- Immune Myopathies: New syndromes <br> - Dermatomysitis

Start Time: 14:00 CEST / 08:00 EDT / 05:00 PDT
Duration: 1hour

Presenations
- Immune Myopathies: New syndromes
- Dermatomysitis

SS 2.0 Metabolic Muscle Diseases (15:00 CEST / 09:00 EDT / 06:00 PDT)
15:00 - 16:00
- Novel therapies in mitochondrial disorders<br> - Novel suggestions in treatment of muscle glycogenoses<br> - Emerging clinical entities in metabolic myopathies

Start Time: 15:00 CEST / 09:00 EDT / 06:00 PDT
Duration: 1hour

- Novel therapies in mitochondrial disorders
- Novel suggestions in treatment of muscle glycogenoses
- Emerging clinical entities in metabolic myopathies

WS 2.0 News in Muscle Imaging MRI (15:00 CEST / 09:00 EDT / 06:00 PDT)
15:00 - 16:00
- Visual representations of muscle MRI data<br> - Unravelling patterns of muscle involvement in distal myopathies <br> - Follow-up of muscle degeneration using quantitative muscle MRI

Start Time: 15:00 CEST / 09:00 EDT / 06:00 PDT
Duration: 1hour

- Visual representations of muscle MRI data
- Unravelling patterns of muscle involvement in distal myopathies
- Follow-up of muscle degeneration using quantitative muscle MRI

SS 3.0 Myotonic Syndromes at the Edge to Fundamental Treatment (16:15 CEST / 10:15 EDT / 07:15 PDT)
16:15 - 17:15
- Non dystrophic myotonias <br> - Natural history and outcomes in DM1 <br> - DM2 standard therapies

Start Time: 16:15 CEST / 10:15 EDT / 07:15 PDT
Duration: 1hour

- Non dystrophic myotonias
- Natural history and outcomes in DM1
- DM2 standard therapies

WS 3.0 Distal and Myofibrillar Myopathies Update (16:15 CEST / 10:15 EDT / 07:15 PDT)
16:15 - 17:15
- New genes causing distal myopathies <br> - Distal myopathy caused myosin and thin filament nebulin <br> - News on myofibrillar myopathies

Start Time: 16:15 CEST / 10:15 EDT / 07:15 PDT
Duration: 1hour

- New genes causing distal myopathies
- Distal myopathy caused myosin and thin filament nebulin
- News on myofibrillar myopathies

Industry Supported Symposia (17:15 CEST / 11:15 EDT / 08:15 PDT)
17:15 - 18:00

Time: 17:15 CEST / 11:15 EDT / 08:15 PDT
Duration: 45 minutes

Muscle Disorders
  • Industry Supported Symposia (12:00 CEST / 06:00 EDT / 03:00 PDT)
    12:00 - 12:45
  • Opening Session (13:00 CEST / 07:00 EDT / 04:00 PDT)
    13:00 - 14:00
  • SS 1.0 News on FSHD (14:00 CEST / 08:00 EDT / 05:00 PDT)
    - FSHD: Setting the Stage
    - FSHD: Genetics, Epigenetics and Genetic Diagnosi
    - FSHD: Biomarkers, Outcome Measures and Therapies
    14:00 - 15:00
  • WS 1.0 Muscle Biopsy (14:00 CEST / 08:00 EDT / 05:00 PDT)
    - Immune Myopathies: New syndromes
    - Dermatomysitis
    14:00 - 15:00
  • SS 2.0 Metabolic Muscle Diseases (15:00 CEST / 09:00 EDT / 06:00 PDT)
    - Novel therapies in mitochondrial disorders
    - Novel suggestions in treatment of muscle glycogenoses
    - Emerging clinical entities in metabolic myopathies
    15:00 - 16:00
  • WS 2.0 News in Muscle Imaging MRI (15:00 CEST / 09:00 EDT / 06:00 PDT)
    - Visual representations of muscle MRI data
    - Unravelling patterns of muscle involvement in distal myopathies
    - Follow-up of muscle degeneration using quantitative muscle MRI
    15:00 - 16:00
  • SS 3.0 Myotonic Syndromes at the Edge to Fundamental Treatment (16:15 CEST / 10:15 EDT / 07:15 PDT)
    - Non dystrophic myotonias
    - Natural history and outcomes in DM1
    - DM2 standard therapies
    16:15 - 17:15
  • WS 3.0 Distal and Myofibrillar Myopathies Update (16:15 CEST / 10:15 EDT / 07:15 PDT)
    - New genes causing distal myopathies
    - Distal myopathy caused myosin and thin filament nebulin
    - News on myofibrillar myopathies
    16:15 - 17:15
  • Industry Supported Symposia (17:15 CEST / 11:15 EDT / 08:15 PDT)
    17:15 - 18:00

12:00
12:10
12:20
12:30
12:40
12:50
13:00
13:10
13:20
13:30
13:40
13:50
14:00
14:10
14:20
14:30
14:40
14:50
15:00
15:10
15:20
15:30
15:40
15:50
16:00
16:10
16:20
16:30
16:40
16:50
17:00
17:10
17:20
17:30
17:40
17:50
18:00
Peripheral Neuropathies
Peripheral Neuropathies
Industry Supported Symposia (12:00 CEST / 06:00 EDT / 03:00 PDT)
12:00 - 12:45

Time: 12:00 CEST / 06:00 EDT / 03:00 PDT
Duration: 45 minutes

SS 4.0 Peripheral Neuropathies; Recent Therapeutic Advances (13:00 CEST / 07:00 EDT / 06:00 PDT)
13:00 - 14:00
- TRR Amyloidosis <br> - SMA <br> - CMT: new treatment concepts and pathways

Start Time: 13:00 CEST / 07:00 EDT / 06:00 PDT
Duration: 1hour

Presenations
- TRR Amyloidosis
- SMA
- CMT: new treatment concepts and pathways

WS 4.0 Paraneoplastic Neuropathies (13:00 CEST / 07:00 EDT / 06:00 PDT)
13:00 - 14:00
- Overview on Paraneoplastic Neuropathies <br> - Paraneoplastic Sensory Neuronopathy <br> - Paraneoplastic Neuromytonia

Start Time: 13:00 CEST / 07:00 EDT / 06:00 PDT
Duration: 1hour

Presenations
- Overview on Paraneoplastic Neuropathies
- Paraneoplastic Sensory Neuronopathy
- Paraneoplastic Neuromytonia

SS 5.0 Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy (14:00 CEST / 08:00 EDT / 05:00 PDT)
14:00 - 15:00
- EAN/PNS guideline on diagnosis and management of Guillain-Barré syndrome <br> - Acute and chronic inflammatory neuropathies and COVID-19 <br> - EAN/PNS guideline on diagnosis and management of chronic inflammatory demyelinating polyradiculoneuropathy - Second revision

Start Time: 14:00 CEST / 08:00 EDT / 05:00 PDT
Duration: 1hour

Presentations:
- EAN/PNS guideline on diagnosis and management of Guillain-Barré syndrome
- Acute and chronic inflammatory neuropathies and COVID-1
- EAN/PNS guideline on diagnosis and management of chronic inflammatory demyelinating polyradiculoneuropathy - Second revision

WS 5.0 Nerve Biopsy (14:00 CEST / 08:00 EDT / 05:00 PDT)
14:00 - 15:00
- From nerve to roots <br> - When to do and how to do <br> - Pathology of the nodal complex in CIDP

Start Time: 14:00 CEST / 08:00 EDT / 05:00 PDT
Duration: 1hour

Presentations:
- From nerve to roots
- When to do and how to do
- Pathology of the nodal complex in CIDP

SS 6.0 Genetic Neuropathies (15:00 CEST / 09:00 EDT / 06:00 PDT)
15:00 - 16:00
- CMT Approach to diagnosis <br> - Autosomal recessive CMT <br> - Early diagnosis of hATTR neuropathy

Start Time: 15:00 CEST / 09:00 EDT / 06:00 PDT
Duration: 1hour

Presentations:
- CMT Approach to diagnosis
- Autosomal recessive CMT
- Early diagnosis of hATTR neuropathy

WS 6.0 Skin Biopsy (15:00 CEST / 09:00 EDT / 06:00 PDT)
15:00 - 16:00
- Clinical indications and normative reference values <br> - Clues on degeneration and regeneration of somatic and autonomic nerves

Start Time: 15:00 CEST / 09:00 EDT / 06:00 PDT
Duration: 1hour

Presentations:
- Clinical indications and normative reference values
- Clues on degeneration and regeneration of somatic and autonomic nerves

Industry Supported Symposia (16:15 CEST / 10:15 EDT / 07:15 PDT)
16:15 - 17:00

Time: 16:15 CEST / 10:15 EDT / 07:15 PDT
Duration: 45 minutes

Peripheral Neuropathies
  • Industry Supported Symposia (12:00 CEST / 06:00 EDT / 03:00 PDT)
    12:00 - 12:45
  • SS 4.0 Peripheral Neuropathies; Recent Therapeutic Advances (13:00 CEST / 07:00 EDT / 06:00 PDT)
    - TRR Amyloidosis
    - SMA
    - CMT: new treatment concepts and pathways
    13:00 - 14:00
  • WS 4.0 Paraneoplastic Neuropathies (13:00 CEST / 07:00 EDT / 06:00 PDT)
    - Overview on Paraneoplastic Neuropathies
    - Paraneoplastic Sensory Neuronopathy
    - Paraneoplastic Neuromytonia
    13:00 - 14:00
  • SS 5.0 Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy (14:00 CEST / 08:00 EDT / 05:00 PDT)
    - EAN/PNS guideline on diagnosis and management of Guillain-Barré syndrome
    - Acute and chronic inflammatory neuropathies and COVID-19
    - EAN/PNS guideline on diagnosis and management of chronic inflammatory demyelinating polyradiculoneuropathy - Second revision
    14:00 - 15:00
  • WS 5.0 Nerve Biopsy (14:00 CEST / 08:00 EDT / 05:00 PDT)
    - From nerve to roots
    - When to do and how to do
    - Pathology of the nodal complex in CIDP
    14:00 - 15:00
  • SS 6.0 Genetic Neuropathies (15:00 CEST / 09:00 EDT / 06:00 PDT)
    - CMT Approach to diagnosis
    - Autosomal recessive CMT
    - Early diagnosis of hATTR neuropathy
    15:00 - 16:00
  • WS 6.0 Skin Biopsy (15:00 CEST / 09:00 EDT / 06:00 PDT)
    - Clinical indications and normative reference values
    - Clues on degeneration and regeneration of somatic and autonomic nerves
    15:00 - 16:00
  • Industry Supported Symposia (16:15 CEST / 10:15 EDT / 07:15 PDT)
    16:15 - 17:00

12:00
12:10
12:20
12:30
12:40
12:50
13:00
13:10
13:20
13:30
13:40
13:50
14:00
14:10
14:20
14:30
14:40
14:50
15:00
15:10
15:20
15:30
15:40
15:50
16:00
16:10
16:20
16:30
16:40
16:50
17:00
17:10
17:20
17:30
17:40
17:50
18:00
Neuromuscular Junction Disorders
Neuromuscular Junction Disorders
Industry Supported Symposia (12:00 CEST / 06:00 EDT / 03:00 PDT)
12:00 - 12:45

Time: 12:00 CEST / 06:00 EDT / 03:00 PDT
Duration: 45 minutes

SS 7.0 MG: Special Clinical Presentations (13:00 CEST / 07:00 EDT / 06:00 PDT)
13:00 - 14:00
- Early onset and Juvenile Myasthenia Gravis <br> - Ocular Myasthenia Gravis <br> - Myasthenia Gravis in seniors

Start Time: 13:00 CEST / 07:00 EDT / 06:00 PDT
Duration: 1hour

Presentations:
- Early onset and Juvenile Myasthenia Gravis
- Ocular Myasthenia Gravis
- Myasthenia Gravis in seniors

WS 7.0 Advances in Dystrophinoapthies (13:00 CEST / 07:00 EDT / 06:00 PDT)
13:00 - 14:00
- Progression of DMD and link between progression and critical milestones, effect of corticosteroids <br> - Dystrophin quantification in diagnostic pathology and clinical trials: implication for diagnosis and translational research <br> - The role of gene modifiers in DMD

Start Time: 13:00 CEST / 07:00 EDT / 06:00 PDT
Duration: 1hour

Presentations:
- Progression of DMD and link between progression and critical milestones, effect of corticosteroids
- Dystrophin quantification in diagnostic pathology and clinical trials: implication for diagnosis and translational research
- The role of gene modifiers in DMD

SS 8.0 Therapy (14:00 CEST / 08:00 EDT / 05:00 PDT)
14:00 - 15:00
- Immunoactive drug therapy <br> - Antisense, RNA silence and other potentials gene therapies in MG <br> - Physical training and exercise as treatment for MG

Start Time: 14:00 CEST / 08:00 EDT / 05:00 PDT
Duration: 1hour

Presentations:
- Immunoactive drug therapy
- Antisense, RNA silence and other potentials gene therapies in MG
- Physical training and exercise as treatment for MG

WS 8.0 Update in Congenital Myopathies (14:00 CEST / 08:00 EDT / 05:00 PDT)
14:00 - 15:00
- Triadopathies <br> - Sarcomeropathies <br> - Congenital Myopathies Across the Ages

Start Time: 14:00 CEST / 08:00 EDT / 05:00 PDT
Duration: 1hour

Presentations:
- Triadopathies
- Sarcomeropathies
- Congenital Myopathies Across the Ages

SS 9.0 Autoantibodies in Myasthenia Gravis (15:00 CEST / 09:00 EDT / 06:00 PDT)
15:00 - 16:00
- LRP4-antibodies <br> - MuSK antibodies <br> - Maternal antibodies – long-term and short-term effects

Start Time: 15:00 CEST / 09:00 EDT / 06:00 PDT
Duration: 1hour

Presentations:
- LRP4-antibodies
- MuSK antibodies
- Maternal antibodies – long-term and short-term effects

WS 9.0 Latest Discoveries in CMS Genes and Pathways (15:00 CEST / 09:00 EDT / 06:00 PDT)
15:00 - 16:00
- CMS related to glycosylation disorders <br> - Extracellular matrix in myasthenic syndromes <br> - Mitochondrial pathology in myasthenic syndromes

Start Time: 15:00 CEST / 09:00 EDT / 06:00 PDT
Duration: 1hour

Presentations:
- CMS related to glycosylation disorders
- Extracellular matrix in myasthenic syndromes
- Mitochondrial pathology in myasthenic syndromes

Industry Supported Symposia (16:15 CEST / 10:15 EDT / 07:15 PDT)
16:15 - 17:00

Time: 16:15 CEST / 10:15 EDT / 07:15 PDT
Duration: 45 minutes

Neuromuscular Junction Disorders
  • Industry Supported Symposia (12:00 CEST / 06:00 EDT / 03:00 PDT)
    12:00 - 12:45
  • SS 7.0 MG: Special Clinical Presentations (13:00 CEST / 07:00 EDT / 06:00 PDT)
    - Early onset and Juvenile Myasthenia Gravis
    - Ocular Myasthenia Gravis
    - Myasthenia Gravis in seniors
    13:00 - 14:00
  • WS 7.0 Advances in Dystrophinoapthies (13:00 CEST / 07:00 EDT / 06:00 PDT)
    - Progression of DMD and link between progression and critical milestones, effect of corticosteroids
    - Dystrophin quantification in diagnostic pathology and clinical trials: implication for diagnosis and translational research
    - The role of gene modifiers in DMD
    13:00 - 14:00
  • SS 8.0 Therapy (14:00 CEST / 08:00 EDT / 05:00 PDT)
    - Immunoactive drug therapy
    - Antisense, RNA silence and other potentials gene therapies in MG
    - Physical training and exercise as treatment for MG
    14:00 - 15:00
  • WS 8.0 Update in Congenital Myopathies (14:00 CEST / 08:00 EDT / 05:00 PDT)
    - Triadopathies
    - Sarcomeropathies
    - Congenital Myopathies Across the Ages
    14:00 - 15:00
  • SS 9.0 Autoantibodies in Myasthenia Gravis (15:00 CEST / 09:00 EDT / 06:00 PDT)
    - LRP4-antibodies
    - MuSK antibodies
    - Maternal antibodies – long-term and short-term effects
    15:00 - 16:00
  • WS 9.0 Latest Discoveries in CMS Genes and Pathways (15:00 CEST / 09:00 EDT / 06:00 PDT)
    - CMS related to glycosylation disorders
    - Extracellular matrix in myasthenic syndromes
    - Mitochondrial pathology in myasthenic syndromes
    15:00 - 16:00
  • Industry Supported Symposia (16:15 CEST / 10:15 EDT / 07:15 PDT)
    16:15 - 17:00

12:00
12:10
12:20
12:30
12:40
12:50
13:00
13:10
13:20
13:30
13:40
13:50
14:00
14:10
14:20
14:30
14:40
14:50
15:00
15:10
15:20
15:30
15:40
15:50
16:00
16:10
16:20
16:30
16:40
16:50
17:00
17:10
17:20
17:30
17:40
17:50
18:00
Motor Neuron Diseases
Motor Neuron Diseases
Industry Supported Symposia (12:00 CEST / 06:00 EDT / 03:00 PDT)
12:00 - 12:45

Time: 12:00 CEST / 06:00 EDT / 03:00 PDT
Duration: 45 minutes

SS 10.0 Advances in ALS therapy (13:00 CEST / 07:00 EDT / 06:00 PDT)
13:00 - 14:00
- Advances in the clinical diagnosis and biomarkers in ALS. Are they ready for clinical trials? <br> - Clinical Trials in ALS <br> - Antisense & SiRNA Therapies

Start Time: 13:00 CEST / 07:00 EDT / 06:00 PDT
Duration: 1hour

Presenations
- Advances in the clinical diagnosis and biomarkers in ALS. Are they ready for clinical trials?
- Clinical Trials in ALS
- Antisense & SiRNA Therapies

WS 10.0 Biomarkers in Motor Neuron Diseases (13:00 CEST / 07:00 EDT / 06:00 PDT)
13:00 - 14:00
Neurophysiology <br> - Imaging <br> - CSF Markers

Start Time: 13:00 CEST / 07:00 EDT / 06:00 PDT
Duration: 1hour

Presentations:
- Neurophysiology
- Imaging
- CSF Markers

SS 11.0 The ALS-FTD Continuum (14:00 CEST / 08:00 EDT / 05:00 PDT)
14:00 - 15:00
- Cognitive and Behavioural Impairment in ALS <br> - Motor Symptoms and Signs in FTD <br> - Genetic and Pathologic Overlap

Start Time: 14:00 CEST / 08:00 EDT / 05:00 PDT
Duration: 1hour

Presentations:
- Cognitive and Behavioural Impairment in ALS
- Motor Symptoms and Signs in FTD
- Genetic and Pathologic Overlap

WS 11.0 Non-5q SMA (14:00 CEST / 08:00 EDT / 05:00 PDT)
14:00 - 15:00
- Tubulinopathies as neurodegenerative disease <br> - Developing treatment for SMARD1 <br> - Developing treatment for Brown-Vialetto-Van Laere Syndrome

Start Time: 14:00 CEST / 08:00 EDT / 05:00 PDT
Duration: 1hour

Presentations:
- Tubulinopathies as neurodegenerative disease
- Developing treatment for SMARD1
- Developing treatment for Brown-Vialetto-Van Laere Syndrome

SS 12.0 Changing the Natural History of SMA (15:00 CEST / 09:00 EDT / 06:00 PDT)
15:00 - 16:00
- Natural history of SMA <br> - SMA registries: what, when and how to register? <br> - New treatments in adult SMA: evidences from the clinical practice

Start Time: 15:00 CEST / 09:00 EDT / 06:00 PDT
Duration: 1hour

Presentations:
- Natural history of SMA
- SMA registries: what, when and how to register?
- New treatments in adult SMA: evidences from the clinical practice

WS 12.0 ALS Management & Palliative Care (15:00 CEST / 09:00 EDT / 06:00 PDT)
15:00 - 16:00
- Multidisciplinary approach of ALS <br> - Technology to improve technical care and trials in MND <br> - Palliative care

Start Time: 15:00 CEST / 09:00 EDT / 06:00 PDT
Duration: 1hour

Presentations:
- Multidisciplinary approach of ALS
- Technology to improve technical care and trials in MND
- Palliative care

Closing Session (16:15 CEST / 10:15 EDT / 07:15 PDT)
16:15 - 17:15

Start Time: 16:15 CEST / 10:15 EDT / 07:15 PDT
Duration: 1hour

Industry Supported Symposia (17:15 CEST / 11:15 EDT / 08:15 PDT)
17:15 - 18:00

Time: 17:15 CEST / 11:15 EDT / 08:15 PDT
Duration: 45 minutes

Motor Neuron Diseases
  • Industry Supported Symposia (12:00 CEST / 06:00 EDT / 03:00 PDT)
    12:00 - 12:45
  • SS 10.0 Advances in ALS therapy (13:00 CEST / 07:00 EDT / 06:00 PDT)
    - Advances in the clinical diagnosis and biomarkers in ALS. Are they ready for clinical trials?
    - Clinical Trials in ALS
    - Antisense & SiRNA Therapies
    13:00 - 14:00
  • WS 10.0 Biomarkers in Motor Neuron Diseases (13:00 CEST / 07:00 EDT / 06:00 PDT)
    Neurophysiology
    - Imaging
    - CSF Markers
    13:00 - 14:00
  • SS 11.0 The ALS-FTD Continuum (14:00 CEST / 08:00 EDT / 05:00 PDT)
    - Cognitive and Behavioural Impairment in ALS
    - Motor Symptoms and Signs in FTD
    - Genetic and Pathologic Overlap
    14:00 - 15:00
  • WS 11.0 Non-5q SMA (14:00 CEST / 08:00 EDT / 05:00 PDT)
    - Tubulinopathies as neurodegenerative disease
    - Developing treatment for SMARD1
    - Developing treatment for Brown-Vialetto-Van Laere Syndrome
    14:00 - 15:00
  • SS 12.0 Changing the Natural History of SMA (15:00 CEST / 09:00 EDT / 06:00 PDT)
    - Natural history of SMA
    - SMA registries: what, when and how to register?
    - New treatments in adult SMA: evidences from the clinical practice
    15:00 - 16:00
  • WS 12.0 ALS Management & Palliative Care (15:00 CEST / 09:00 EDT / 06:00 PDT)
    - Multidisciplinary approach of ALS
    - Technology to improve technical care and trials in MND
    - Palliative care
    15:00 - 16:00
  • Closing Session (16:15 CEST / 10:15 EDT / 07:15 PDT)
    16:15 - 17:15
  • Industry Supported Symposia (17:15 CEST / 11:15 EDT / 08:15 PDT)
    17:15 - 18:00

CME Information

The ICNMD 2021 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 17 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA
Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Credits will be awarded for ICNMD 2021 sessions viewed live through May 29, 2021. Each participant can only receive the number of credits they are entitled to according to their
actual participation after completing the evaluation form. Evaluation forms must be submitted within two weeks on Congress.

The ICNMD2021 virtual library access will expire on 5 April 2022.


  •  

    The ICNMD is organized on behalf of the Applied Research Group on Neuromuscular Diseases of the World Federation of Neurology.
  • Stay Connected

    Keep up to date with Congress News & Alerts.
    Sign Up

     

    #ICNMD2022

  • ICNMD 2022 Congress Secretariat
    ICS International Conference Services LTD (ICS)
    710 – 1201 West Pender Street
    Vancouver, BC, Canada V6E 2V2
    P: [+1] 604 681 2153
    E: icnmd2022@icsevents.com
    Web: icnmd.org
© 2022 International Congress on Neuromuscular Diseases